PMA: BP140143
Device Generic Name: Pathogen Reduction System for Platelets
Tradename: INTERCEPT® Blood System for Platelets
Manufacturer: Cerus Corporation
Indications:

• Intended to be used for ex vivo preparation of apheresis platelet components in order to reduce the risk of transfusion-transmitted infection (TTI) including sepsis, and to potentially reduce the risk of transfusion-associated graft versus host disease (TA-GVHD).

Approval Date: December 18, 2014

Product Information

• Package Insert - INTERCEPT Blood System for Platelets - Dual Storage (DS) Processing Set
• Package Insert - INTERCEPT Blood System for Platelets - Large Volume (LV) Processing Set
• Package Insert - INTERCEPT Blood System for Platelets - Small Volume (SV) Processing Set

Supporting Documents

• Supporting Documents older than three years - INTERCEPT Blood System for Platelets